Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_provenance.
- NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_assertion description "[RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_provenance.
- NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_assertion evidence source_evidence_literature NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_provenance.
- NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_assertion SIO_000772 18202228 NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_provenance.
- NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_assertion wasDerivedFrom befree-2016 NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_provenance.
- NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_assertion wasGeneratedBy ECO_0000203 NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_provenance.
- befree-2016 importedOn "2016-02-19" NP650493.RAUIJnW1ideR4epk2FHKY4JI63FfZ1SKD7c7MjJq-r2jU130_provenance.